As of November 6, 2026, Aimei Health Technology Co., Ltd. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 29, 2026, naming 1 appointment and 1 departure. The latest filing names Julianne Huh, leaving (Form 8-K, June 29, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Aimei Health Technology Co., Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Aimei Health Technology Co., Ltd. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-29. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Aimei Health Technology Co., Ltd. files it.
Also on the record for Aimei Health Technology Co., Ltd.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 10, 2026 | Stake report, Schedule 13G/A, by First Trust Capital Management L.P. | 21.48% of the class | 5%+ stakes | Source |
| August 5, 2026 | Stake report, Schedule 13G/A, by W. R. Berkley Corporation | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Mizuho Financial Group, Inc. | — | 5%+ stakes | Source |
| January 7, 2026 | Stake report, Schedule 13G/A, by KARPUS MANAGEMENT, INC. | 1.28% of the class | 5%+ stakes | Source |
| November 7, 2025 | Stake report, Schedule 13G/A, by WOLVERINE ASSET MANAGEMENT LLC | — | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G/A, by Mizuho Financial Group, Inc. | 9% of the class | 5%+ stakes | Source |
| August 8, 2025 | Stake report, Schedule 13G/A, by W. R. Berkley Corporation | 6.9% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Aimei Health Technology Co., Ltd. now and the warning signs.
Free to see. No signup.
Keep reading
More on Aimei Health Technology Co., Ltd. and the records around it.
Aimei Health Technology Co., Ltd. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- First Trust Merger Arbitrage Fund also filed stake reports on 47 other companies: TCW SPECIALTY LENDING LLC (Sep 2026), Blue Foundry Bancorp (Aug 2026), Centurion Acquisition Corp. (Aug 2026)
- Mizuho Financial Group, Inc. also filed stake reports on 74 other companies: Aeon Acquisition I Corp. (Aug 2026), Alpex Acquisition Corp (Aug 2026), Aperture AC (Aug 2026)
- WOLVERINE ASSET MANAGEMENT LLC also filed stake reports on 75 other companies: Black Hawk Acquisition Corp (Nov 2026), AmperCap Acquisition Company (Oct 2026), BTC Development Corp. (Oct 2026)
Watch Aimei Health Technology Co., Ltd.
Get an email when Aimei Health Technology Co., Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Aimei Health Technology Co., Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Aimei Health Technology Co., Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aimei Health Technology Co., Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-29 | Out | 8-K, 2026-06-29 | |||
| 2026-06-29 | In | Director | 8-K, 2026-06-29 |
Who leads Aimei Health Technology Co., Ltd., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Daniel Veikko Polvi, appointed (filed 2026-06-29).
New leaders reset buying decisions — get the Full Report on Aimei Health Technology Co., Ltd.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Aimei Health Technology Co., Ltd., with the record behind each one.
Find candidates like Director at Aimei Health Technology Co., Ltd.Every change, in the filing's words
Departing: Julianne Huh
Ms. Huh has advised the Company that her resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company.
Appointed: Daniel Veikko Polvi, Director
On June 29, 2026, the nominating and corporate governance committee of the Board recommended, and the Board approved and appointed Mr. Daniel Veikko Polvi to serve as a director of the Company.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
- On June 24, 2026, Ms. Julianne Huh, a director of Aimei Health Technology Co., Ltd (the "Company"), submitted a letter of resignation indicating her intention to resign as the Company's director, effective June 24, 2026, which has been accepted by the board of directors of the Company (the "Board").
- Ms. Huh has acknowledged that she has been paid all amounts due to her and she is not entitled to any payments or benefits of any kind from the Company, and she has irrevocably and unconditionally released the Company of and from all claims, demands, actions, and causes of action.
- Mr. Polvi received his MBA degree in Business Administration from BI Norwegian Business School in June 2018.
- Since May 2019, Mr. Polvi has served as the managing director of Shearwater Limited, a management consulting firm providing business management consulting services to international corporations, where he is responsible for overseeing client engagements and delivering business and management consulting services to international corporate clients.
- The Board believes that Mr. Polvi is well qualified to serve as a director of the Company due to his extensive experience in business management, corporate advisory, and strategic consulting for international corporations.
Tools for this story
Each opens in a new tab, filled in for Aimei Health Technology Co., Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.